Bank of New York Mellon’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-61,907
| Closed | -$344K | – | 4184 |
|
|
2024
Q2 | $344K | Buy |
+61,907
| New | +$220K | ﹤0.01% | 3755 |
|
|
2019
Q4 | – | Sell |
-1,706
| Closed | -$14K | – | 4242 |
|
|
2019
Q3 | $14K | Hold |
1,706
| – | – | ﹤0.01% | 4200 |
|
|
2019
Q2 | $23K | Hold |
1,706
| – | – | ﹤0.01% | 4187 |
|
|
2019
Q1 | $27K | Sell |
1,706
-42
| -2% | -$639 | ﹤0.01% | 4141 |
|
|
2018
Q4 | $19K | Hold |
1,748
| – | – | ﹤0.01% | 4164 |
|
|
2018
Q3 | $26K | Sell |
1,748
-67
| -4% | -$1.02K | ﹤0.01% | 4195 |
|
|
2018
Q2 | $27K | Sell |
1,815
-572
| -24% | -$8.04K | ﹤0.01% | 4152 |
|
|
2018
Q1 | $37K | Buy |
2,387
+499
| +26% | +$8.85K | ﹤0.01% | 4208 |
|
|
2017
Q4 | $37K | Buy |
1,888
+73
| +4% | +$1.43K | ﹤0.01% | 4243 |
|
|
2017
Q3 | $36K | Hold |
1,815
| – | – | ﹤0.01% | 4160 |
|
|
2017
Q2 | $37K | Sell |
1,815
-350
| -16% | -$7.5K | ﹤0.01% | 4173 |
|
|
2017
Q1 | $45K | Buy |
2,165
+337
| +18% | +$6.49K | ﹤0.01% | 4151 |
|
|
2016
Q4 | $29K | Sell |
1,828
-95
| -5% | -$1.74K | ﹤0.01% | 4183 |
|
|
2016
Q3 | $43K | Buy |
1,923
+237
| +14% | +$5.46K | ﹤0.01% | 4157 |
|
|
2016
Q2 | $31K | Sell |
1,686
-6,025
| -78% | -$160K | ﹤0.01% | 4240 |
|
|
2016
Q1 | $202K | Buy |
7,711
+1,447
| +23% | +$45K | ﹤0.01% | 3788 |
|
|
2015
Q4 | $227K | Sell |
6,264
-11
| -0.2% | -$477 | ﹤0.01% | 3826 |
|
|
2015
Q3 | $208K | Sell |
6,275
-1,421
| -18% | -$80K | ﹤0.01% | 3893 |
|
|
2015
Q2 | $533K | Buy |
7,696
+186
| +2% | +$12.8K | ﹤0.01% | 3613 |
|
|
2015
Q1 | $564K | Sell |
7,510
-6
| -0.1% | -$472 | ﹤0.01% | 3558 |
|
|
2014
Q4 | $625K | Sell |
7,516
-227
| -3% | -$18.4K | ﹤0.01% | 3527 |
|
|
2014
Q3 | $629K | Buy |
7,743
+267
| +4% | +$22.8K | ﹤0.01% | 3540 |
|
|
2014
Q2 | $670K | Buy |
7,476
+1,970
| +36% | +$175K | ﹤0.01% | 3516 |
|
|
2014
Q1 | $652K | Buy |
5,506
+704
| +15% | +$68.4K | ﹤0.01% | 3483 |
|
|
2013
Q4 | $338K | Buy |
4,802
+164
| +4% | +$6.68K | ﹤0.01% | 3712 |
|
|
2013
Q3 | $262K | Sell |
4,638
-13
| -0.3% | -$816 | ﹤0.01% | 3710 |
|
|
2013
Q2 | $341K | Buy |
+4,651
| New | +$268K | ﹤0.01% | 3633 |
|
Bank of New York Mellon's ALIM Position: Q3 2024 in Review
Bank of New York Mellon sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 61,907 shares — an estimated $344K sold.
Bank of New York Mellon first reported a position in ALIM in Q2 2013 and held it in 27 quarters. The position peaked at $670K in Q2 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Bank of New York Mellon reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Bank of New York Mellon sold 61,907 Alimera Sciences shares in Q3 2024, an estimated $344K.
- Bank of New York Mellon first reported a position in Alimera Sciences in Q2 2013 and held it in 27 quarters.
- Bank of New York Mellon's Alimera Sciences position peaked at $670K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Bank of New York Mellon's 13F filing for Q3 2024, filed 12 Nov 2024.